Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041778 | SCV000065474 | benign | not specified | 2013-03-07 | criteria provided, single submitter | clinical testing | Arg5031Trp in exon 70 of USH2A: This variant is not expected to have clinical si gnificance because it has been identified in 1.3% (167/12839) of chromosomes fr om a broad population by the NHLBI Exome sequencing project (http://evs.gs.washi ngton.edu/EVS/; dbSNP rs56038610) and is reported as benign in Dreyer et al. 200 8. |
Gene |
RCV000041778 | SCV000169775 | benign | not specified | 2014-01-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000041778 | SCV000707025 | benign | not specified | 2017-03-28 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000674670 | SCV000800051 | likely benign | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000087008 | SCV001146604 | benign | not provided | 2018-09-20 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000087008 | SCV001156939 | benign | not provided | 2023-10-06 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000087008 | SCV001719827 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001271911 | SCV001748646 | likely benign | Usher syndrome type 2A | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000041778 | SCV002051060 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000087008 | SCV003916550 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | USH2A: BP4, BS1, BS2 |
NEI Ophthalmic Genomics Laboratory, |
RCV000087008 | SCV000119261 | not provided | not provided | no assertion provided | not provided | ||
Natera, |
RCV001271911 | SCV001453406 | benign | Usher syndrome type 2A | 2019-08-29 | no assertion criteria provided | clinical testing |